Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy

    Thumbnail
    Citations
    Scopus
    Web of Science
    Altmetric
    17
    16
    Author
    Fominskiy, E; Scandroglio, AM; Monti, G; Calabro, MG; Landoni, G; Dell'Acqua, A; Beretta, L; Moizo, E; Ravizza, A; Monaco, F; ...
    Date
    2021-01-01
    Source Title
    Blood Purification
    Publisher
    KARGER
    University of Melbourne Author/s
    Bellomo, Rinaldo
    Affiliation
    Critical Care
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Fominskiy, E., Scandroglio, A. M., Monti, G., Calabro, M. G., Landoni, G., Dell'Acqua, A., Beretta, L., Moizo, E., Ravizza, A., Monaco, F., Campochiaro, C., Pieri, M., Azzolini, M. L., Borghi, G., Crivellari, M., Conte, C., Mattioli, C., Silvani, P., Mucci, M. ,... Zangrillo, A. (2021). Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy. BLOOD PURIFICATION, 50 (1), pp.102-109. https://doi.org/10.1159/000508657.
    Access Status
    Access this item via the Open Access location
    URI
    http://hdl.handle.net/11343/278590
    DOI
    10.1159/000508657
    Open Access URL
    Published version
    Abstract
    BACKGROUND: There is no information on acute kidney injury (AKI) and continuous renal replacement therapy (CRRT) among invasively ventilated coronavirus disease 2019 (COVID-19) patients in Western healthcare systems. OBJECTIVE: To study the prevalence, characteristics, risk factors and outcome of AKI and CRRT among invasively ventilated COVID-19 patients. METHODS: Observational study in a tertiary care hospital in Milan, Italy. RESULTS: Among 99 patients, 72 (75.0%) developed AKI and 17 (17.7%) received CRRT. Most of the patients developed stage 1 AKI (33 [45.8%]), while 15 (20.8%) developed stage 2 AKI and 24 (33.4%) a stage 3 AKI. Patients who developed AKI or needed CRRT at latest follow-up were older, and among CRRT treated patients a greater proportion had preexisting CKD. Hospital mortality was 38.9% for AKI and 52.9% for CRRT patients. CONCLUSIONS: Among invasively ventilated COVID-19 patients, AKI is very common and CRRT use is common. Both carry a high risk of in-hospital mortality.

    Export Reference in RIS Format     

    Collections